WILMINGTON TREATMENT CENTER INC — History
CCN 340168 | 3-year financial timeline | COVID resilience: 63/100
🛡️ Public data only — no PHI permitted on this instance.
$32M
Latest Revenue (FY2022)
+12.1%
Revenue CAGR (3yr)
19.9%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $26M | $30M | $32M | +9.6% | +12.1% |
| Operating Expenses | $20M | $22M | $26M | +15.9% | +13.6% |
| Operating Margin | 21.9% | 24.2% | 19.9% | -17.9% | -4.8% |
| Net Income | $6M | $7M | $6M | -10.0% | +6.8% |
| Licensed Beds | 92 | 92 | 92 | +0.0% | +0.0% |
| Total Patient Days | 17,879 | 23,012 | 24,437 | +6.2% | +16.9% |
| Medicare Day % | 13% | 8% | 8% | +0.2% | -20.1% |
| Medicaid Day % | nan% | nan% | nan% | +nan% | +nan% |
COVID Impact & Recovery
Resilience Score: 63/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +25.7% ($26M → $32M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+12.1%
This Hospital
+7.6%
State Avg
Latest Margin
19.9%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $36M | 18.9% |
| FY2024 (proj) | $39M | 17.9% |
| FY2025 (proj) | $42M | 16.8% |